AAOpt 2024: Keeping contact lens wearers comfortable with Miebo

News
Video

David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.

David Geffen, OD, FAAO presented on his research using the eye drop perfluorohexyloctane, also known as Miebo, for contact lens wearers. His poster was titled, "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers."

Geffen explained that one of the main reasons for contact lens dropout is dry eye and discomfort. His study enrolled 46 contact lens wearers - 26 daily wearers and 20 monthly wearers - and had them use the Mibo drops 4 times per day for 30 days. The study looked at various metrics like meibomian scores, staining, visual acuity, osmolarity, and contact lens comfort. Surprisingly, the only statistically significant change was an increase in contact lens comfort. Geffen noted that most of the study participants continued using the drops with their contacts after the study concluded. Based on these findings, Geffen believes Mibo could be a valuable tool for improving contact lens retention and reducing dropouts due to discomfort. He stated that plans should be made to conduct further studies to see if the drops can be used directly on the contact lenses without any issues.

Currently, Geffen and many of his colleagues are already using Miebo off-label for contact lens patients, with good results. The main considerations are ensuring patients use the right drop size and frequency (2-3 times per day may be sufficient). Overall, there is an exciting potential new application for Mibo that could transform the contact lens experience for many patients. While more research is needed, the initial findings are very promising in terms of improving comfort and potentially reducing contact lens dropout rates long-term.

Recent Videos
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
For Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, last week's conference gives a unique opportunity for optometrists and ophthalmologists to collaborate.
Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
© 2025 MJH Life Sciences

All rights reserved.